Anticoagulation for the acute management of ischemic stroke

Yale Journal of Biology and Medicine

Volumn 87, Issue 2, 2014, Pages 199-206

  Robinson, Austin A ^a   Ikuta, Kevin ^a   Soverow, Jonathan ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anticoagulation; Cardioembolism; Hemorrhagic transformation; Intracardiac thrombus; Ischemic stroke; Left ventricular thrombus

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; HEPARINOID; LOW MOLECULAR WEIGHT HEPARIN;

ANTICOAGULANT THERAPY; ATAXIC APHASIA; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; DRUG SAFETY; HEART VENTRICLE THROMBOSIS; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; REVIEW; RISK ASSESSMENT; TIME TO TREATMENT; TRANSTHORACIC ECHOCARDIOGRAPHY; ACUTE DISEASE; COMPLICATION; RECURRENT DISEASE; STROKE; TIME;

ACUTE DISEASE; ANTICOAGULANTS; BRAIN ISCHEMIA; HUMANS; RECURRENCE; STROKE; TIME FACTORS;

EID: 84902120858     PISSN: 00440086     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Fields JD, Lutsep HL, Rymer MR, Budzik RF, Devlin TG, Baxter BW, et al. Endovascular Mechanical Thrombectomy for the Treatment of Acute Ischemic Stroke Due to Arterial Dissection. Interv Neuroradiol. 2012;18(1):74-9.
2. Pereira VM, Gralla J, Davalos A, Bonafé A, Castaño C, Chapot R, et al. Prospective, Multicenter, Single-Arm Study of Mechanical Thrombectomy Using Solitaire Flow Restoration in Acute Ischemic. Stroke. 2013;44(10):2802-7.
3. Ciccone A, Valvassori L, Nichelatti M, Sgoifo A, Ponzio M, Sterzi R, et al. Endovascular Treatment for Acute Ischemic Stroke. N Engl J Med. 2013;368(10):904-13.
4. Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, et al. Endovascular Therapy after Intravenous t-PA versus t-PA Alone for Stroke. N Engl J Med. 2013;368(10):893-903.
5. Millikan CH, Siekert RG, Shick RM. Studies in cerebrovascular disease. III. The use of anticoagulant drugs in the treatment of insufficiency or thrombosis within the basilar arterial system. Proc Staff Meet Mayo Clin. 1955;30(6):116-26.
6. Carey LC, Williams RD. Comparative Effects of Dicoumarol, Tromexan, and Heparin on Thrombus Propagation. Ann Surg. 1960;152(5):919-22.
7. Hyers TM, Agnelli G, Hull RD, Morris TA, Samama M, Tapson V, et al. Antithrombotic therapy for venous thromboembolic disease. Chest. 2001;119(1 Suppl):176S-93S.
8. Byer JA, Easton JD. Therapy of ischemic cerebrovascular disease. Ann Intern Med. 1980;93(5):742-56.
9. Miller VT, Hart RG. Heparin anticoagulation in acute brain ischemia. Stroke. 1988;19(3):403-6.
10. Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008. Cerebrovasc Dis. 2008;25(5):457-507.
11. Jauch EC, Saver JL, Adams HPJ, Bruno A, Connors JJ, Demaerschalk BM, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2013;44(3):870-947.
12. Rödén-Jüllig Å, Britton M. Effectiveness of heparin treatment for progressing ischaemic stroke: before and after study. J Intern Med. 2000;248(4):287-91.
13. Teal PA, Pessin MS. Hemorrhagic transformation. The spectrum of ischemia-related brain hemorrhage. Neurosurg Clin N Am. 1992;3(3):601-10.
14. Kazmierski R, Michalak S, Wencel-Warot A, Nowinski WL. Serum tight-junction proteins predict hemorrhagic transformation in ischemic stroke patients. Neurology. 2012;79(16):1677-85.
15. Sandercock PA, Counsell C, Kamal AK. Anticoagulants for Acute Ischaemic Stroke. The Cochrane Library [Internet]. 15 Apr 2009. [cited 21 Mar 2013]. Available from: http://onlinelibrary.wiley.com/doi/10.1002/1 4651858.CD000024.pub3/abstract.
16. Bamford J, Sandercock P, Dennis M, Warlow C, Burn J. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991;337(8756):1521-6.
17. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35-41.
18. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, Simone GD, et al. Heart Disease and Stroke Statistics-2010 Update. A Report From the American Heart Association. Circulation [Internet]. 17 Dec 2009 [cited 8 Oct 2013]; Available from: http://circ.ahajournals.org/content/early/2009 /12/17/CIRCULATIONAHA.109.192667.
19. Hart RG, Coull BM, Hart D. Early recurrent embolism associated with nonvalvular atrial fibrillation: a retrospective study. Stroke. 1983;14(5):688-93.
20. Kelley RE, Berger JR, Alter M, Kovacs AG. Cerebral ischemia and atrial fibrillation: prospective study. Neurology. 1984;34(10):1285-91.
21. Paciaroni M, Agnelli G, Micheli S, Caso V. Efficacy and Safety of Anticoagulant Treatment in Acute Cardioembolic Stroke: A Meta-Analysis of Randomized Controlled Trials. Stroke. 2007;38(2):423-30.
22. Berge E, Abdelnoor M, Nakstad P, Sandset P. Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. Lancet. 2000;355(9211):1205-10.
23. Immediate anticoagulation of embolic stroke: brain hemorrhage and management options. Cerebral Embolism Study Group. Stroke. 1984;15(5):779-89.
24. Lansberg MG, O'Donnell MJ, Khatri P, Lang ES, Nguyen-Huynh MN, Schwartz NE, et al. Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic therapy and prevention of thrombosis, 9th ed: american college of chest physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e601S-36S.
25. Çelik Y, Utku U, Asil T, Balci{dotless} K. Factors Affecting Haemorrhagic Transformation in Middle Cerebral Artery Infarctions. J Clin Neurosci. 2004;11(6):656-8.
26. Von Kummer R, Allen KL, Holle R, Bozzao L, Bastianello S, Manelfe C, et al. Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology. 1997;205(2):327-33.
27. Mandzia JL, Hill MD. Acute Stroke Management in Patients With Known or Suspected Atrial Fibrillation. Can J Cardiol. 2013;29(7 Suppl):S45-53.
28. Chiarella F, Santoro E, Domenicucci S, Maggioni A, Vecchio C. Predischarge Two-Dimensional Echocardiographic Evaluation of Left Ventricular Thrombosis After Acute Myocardial Infarction in the GISSI-3 Study. Am J Cardiol. 1998;81(7):822-7.
29. Gottdiener JS, Gay JA, VanVoorhees L, DiBianco R, Fletcher RD. Frequency and Embolic Potential of Left Ventricular Thrombus in Dilated Cardiomyopathy: Assessment by 2-Dimensional Echocardiography. Am J Cardiol. 1983;52(10):1281-5.
30. Lapeyre III AC, Steele PM, Kazmier FJ, Chesebro JH, Vlietstra RE, Fuster V. Systemic Embolism in Chronic Left Ventricular Aneurysm: Incidence and the Role of Anticoagulation. J Am Coll Cardiol. 1985;6(3):534-8.
31. Haugland JM, Asinger RW, Mikell FL, Elsperger J, Hodges M. Embolic potential of left Ventricular Thrombi Detected by Two-Dimensional Echocardiography. Circulation. 1984;70(4):588-98.
32. Stratton JR, Resnick AD. Increased embolic risk in patients with left ventricular thrombi. Circulation. 1987;75(5):1004-11.
33. Howell D, Kyser F. The Effect Of Anticoagulant Therapy Upon the Development of Mural Thrombosis Following Myocardial Infarction. Ann Intern Med. 1954;40(4):694-7.
34. Lee JM, Park JJ, Jung HW, Cho Y-S, Oh I-Y, Yoon C-H, et al. Left Ventricular Thrombus and Subsequent Thromboembolism, Comparison of Anticoagulation, Surgical Removal, and Antiplatelet Agents. J Atheroscler Thromb. 2013;20(1):73-93.
35. Leick J, Szardien S, Liebetrau C, Willmer M, Fischer-Rasokat U, Kempfert J, et al. Mobile left ventricular thrombus in left ventricular dysfunction: case report and review of literature. Clin Res Cardiol. 2013;102(7):479-84.
36. Egolum UO, Stover DG, Anthony R, Wasserman AM, Lenihan D, Damp JB. Intracardiac Thrombus: Diagnosis, Complications and Management. Am J Med Sci. 2013;345(5):391-5.
37. Suzuki R, Kudo T, Kurazumi H, Takahashi M, Shirasawa B, Mikamo A, et al. Transapical extirpation of a left ventricular thrombus in takotsubo cardiomyopathy. J Cardiothorac Surg. 2013;8(1):135.
38. Heik SCW, Kupper W, Hamm C, Bleifeld W, Koschyk DH, Waters D, et al. Efficacy of High Dose Intravenous Heparin for Treatment of Left Ventricular Thrombi with High Embolic Risk. J Am Coll Cardiol. 1994;24(5):1305-9.
39. Vaitkus PT, Barnathan ES. Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: A meta-analysis. J Am Coll Cardiol. 1993;22(4):1004-9.
40. Mallory R, Balcezak T. Treatment of Mobile Left Ventricular Thrombus with Low-Molecular-Weight Heparin. N Engl J Med. 1999;341(14):1082-3.
41. Meurin P, Tabet JY, Renaud N, Weber H, Grosdemouge A, Bourmayan C, et al. Treatment of left ventricular thrombi with a low molecular weight heparin. Int J Cardiol. 2005;98(2):319-23.
42. Vandvik PO, Lincoff AM, Gore JM, Gutterman DD, Sonnenberg FA, Alonso-Coello P, et al. Primary and secondary prevention of cardiovascular disease: Antithrombotic therapy and prevention of thrombosis, 9th ed: american college of chest physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 suppl):e637S-68S.
43. Whitlock RP, Sun JC, Fremes SE, Rubens FD, Teoh KH. Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic therapy and prevention of thrombosis, 9th ed: american college of chest physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 suppl):e576S-600S.
44. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Low molecular weight heparinoid, org 10172 (danaparoid), and outcome after acute ischemic stroke: A randomized controlled trial. JAMA. 1998;279(16):1265-72.
45. Lyrer P, Engelter S. Antithrombotic drugs for carotid artery dissection. Cochrane Database Syst Rev. 2010;(10):CD000255.
46. Kennedy F, Lanfranconi S, Hicks C, Reid J, Gompertz P, Price C, et al. Antiplatelets vs anticoagulation for dissection: CADISS nonrandomized arm and meta-analysis. Neurology. 2012;79(7):686-9.
47. Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SCP, et al. Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2011;42(1):227-76.
48. Eikelboom JW, Connolly SJ, Brueckmann M, Granger CB, Kappetein AP, Mack MJ, et al. Dabigatran versus Warfarin in Patients with Mechanical Heart Valves. N Engl J Med. 2013;369(13):1206-14.
49. Tissue Plasminogen Activator for Acute Ischemic Stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333(24):1581-8.
50. Schmulling S, Rudolf J, Strotmann-Tack T, Grond M, Schneweis S, Sobesky J, et al. Acetylsalicylic Acid Pretreatment, Concomitant Heparin Therapy and the Risk of Early Intracranial Hemorrhage following Systemic Thrombolysis for Acute Ischemic Stroke. Cerebrovasc Dis. 2003;16(3):183-90.
51. Grond M, Rudolf J, Neveling M, Stenzel C, Heiss W-D. Risk of Immediate Heparin after rt-PA Therapy in Acute Ischemic Stroke. Cerebrovasc Dis. 1997;7(6):318-23.